More than 10,000 specially trained dentists and their staffs will dedicate five days to a specific theme aimed at raising awareness of safe sedation dentistry

Imagine a drug that has 30 times as much pain-relieving power as morphine but that doesn’t addict patients. That’s what researchers hope they’ve found in

Hypnoz Therapeutic Devices has signed an agreement with LMA North America to distribute its Jaw Elevation Device (JED), a noninvasive device designed to assist dentists

A majority of patients and dentists gave favorable assessments of the drug OraVerse (phentolamine mesylate), which reverses the effects of local anesthesia, according to a

To curb prescription fraud and abuse, the state of Washington will require all prescriptions to be printed on tamper-resistant paper with ink that changes color

Novalar Pharmaceuticals has entered into an exclusive license and distribution agreement with Sanofi-Aventis Deutschland to offer its vasodilator drug phentolamine mesylate, OraVerse, in Germany beginning

DentalVibe, a new dental device that its developers claim takes the fear and pain out of dental injections, was introduced last week at the Chicago

The U.S. FDA has asked Novalar Pharmaceuticals to stop distributing a patient brochure for the drug OraVerse (phentolamine mesylate), which it markets for reversing the